{"url_path":"/sec/tela/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1561921/0001104659-26-060234-index.html","accession_number":"0001104659-26-060234","cik":"0001561921","ticker":"TELA","issuer_name":"TELA Bio, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1561921/0001104659-26-060234-index.html","primary_entity_key":"0001561921","primary_entity_name":"TELA Bio, Inc."},"word_count":58,"has_tables":true,"body_markdown":"**Item 5. Other Information.**\n\n​\n\n**Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements**\n\n​\n\nDuring the three months ended March 31, 2026, none of our directors or officers adopted, terminated or modified a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as defined in Item 408(a) of Regulation S-K of the Exchange Act.\n\n​\n\n31\n\n[Table of Contents](#TOC)"}